Clinical Trial

Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC

Name: Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC — clinical trial record (NCT07490002)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a single-arm, exploratory clinical study.

Trial Details

NCT Number	NCT07490002
Lead Sponsor	Changhai Hospital
Conditions	Esophageal Squamous Carcinoma
Enrollment	33 participants
Start Date	2026-04-06
Primary Completion	2028-11-30 (estimated)
Study Completion	2030-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-24